Last quarter (Q3 2024), Mydecine Innovations Group's total revenue was $―, a decrease of ― from the same quarter last year. In Q3, Mydecine Innovations Group's net income was $-1.99M. See Mydecine Innovations Group’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Total Revenue	$ ―	$ ―	$ ―	$ 7.49K	$ 2.62K	$ 125.57K
Cost of Revenue	$ ―	$ ―	$ ―	$ ―	$ ―	$ 94.05K
Gross Profit	$ ―	$ ―	$ ―	$ 7.49K	$ 2.62K	$ 31.52K
Operating Expense	$ 6.90M	$ 9.55M	$ 16.39M	$ 22.69M	$ 11.46M	$ 3.43M
Operating Income	$ -6.90M	$ -9.55M	$ -16.39M	$ -22.68M	$ -11.46M	$ -3.39M
Net Non Operating Interest Income Expense	$ -1.68M	$ -1.30M	$ -664.07K	$ 205.27K	$ 182.87K	$ 80.52K
Other Income Expense	$ 4.72M	$ 8.81M	$ 12.69K	$ -693.51K	$ -15.23M	$ -17.95M
Pretax Income	$ -14.60M	$ -20.95M	$ -17.24M	$ -23.58M	$ -26.88M	$ -21.43M
Tax Provision	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Earnings From Equity Interest Net Of Tax	$ ―	$ ―	$ ―	$ ―	$ 333.60K	$ ―
Net Income Common Stockholders	$ -23.30M	$ -20.95M	$ -11.57M	$ -28.90M	$ -26.95M	$ -21.43M
Basic EPS	$ -0.06	$ -0.68	$ ―	$ ―	$ ―	$ ―
Diluted EPS	$ -0.06	$ -0.68	$ ―	$ ―	$ ―	$ ―
Basic Average Shares	$ 227.07M	$ 30.70M	$ ―	$ ―	$ ―	$ ―
Diluted Average Shares	$ 227.07M	$ 30.70M	$ ―	$ ―	$ ―	$ ―
Dividend Per Share	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Total Operating Income As Reported	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Basic E P S	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Diluted E P S	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Rent Expense Supplemental	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Total Expenses	$ 6.90M	$ 9.55M	$ 16.39M	$ -22.69M	$ -11.46M	$ -3.52M
Net Income From Continuing And Discontinued Operation	$ -23.30M	$ -20.95M	$ -11.57M	$ -28.90M	$ -26.95M	$ -21.43M
Normalized Income	$ -10.90M	$ -14.11M	$ -12.36M	$ -17.33M	$ -3.65M	$ 2.36M
Interest Expense	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
EBIT	$ -3.35M	$ -19.64M	$ -16.33M	$ -23.38M	$ -26.69M	$ -21.35M
EBITDA	$ -3.35M	$ -19.63M	$ -16.20M	$ -23.14M	$ -26.64M	$ -21.30M

Currency in USD

Mydecine Innovations Group Earnings and Revenue History

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing